Jason Broderick
Articles
Women Who Receive Organ-Sparing Robotic Cystectomy Experience Preserved Sexual, Urinary Function
December 07, 2021
Article
A retrospective study presented at the 22nd SUO Annual Meeting revealed that pelvic organ–preserving robot-assisted radical cystectomy allowed women to return to sexual activity post-surgery.
PSA Screening Leads to Better Outcomes in Young African Americans
May 20, 2021
Article
There is an association between increased prostate-specific antigen (PSA) screening and improved outcomes in younger African American patients.
YouTube Videos Spread Cancer Misinformation
May 09, 2021
Article
Studies found that misinformation and bias is prevalent in YouTube videos about prostate and bladder cancer.
FDA Approves Atezolizumab for PD-L1 High NSCLC
May 19, 2020
Article
The FDA has approved the single-agent atezolizumab as a first-line treatment for patients with metastatic non-small cell lung cancer who have a high PD-L1 expression and no EGFR or ALK genomic tumor aberrations.
Dasatinib Approved for Pediatric Ph+ Chronic Phase CML
November 10, 2017
Article
Dasatinib (Sprycel) has been approved by the FDA to treat pediatric patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP).